Clinical trials: Gambling Disorder
Pathological Gambling
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
This study is designed to test the hypothesis that ecopipam is able to reduce urges to gamble in patients diagnosed with Pathological Gambling.
- Trial name
- NCT01215357
- Testing
- Ecopipam
- Where
- 4 sites in United States
- Volunteers
- 34 people
- Sponsor
- Emalex Biosciences Inc.
Pathological Gambling
Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling
The purpose of this study is to determine if nalmefene is safe and effective in the treatment of pathological gambling.
- Trial name
- NCT00132119
- Testing
- nalmefene HCl
- Volunteers
- 233 people
- Sponsor
- Somaxon Pharmaceuticals
Gambling Addiction
Validation of Kaihani Score for Gambling Addiction
The Kaihani Score is a blood based means of assessing molecules believed to be associated with gambling addiction. The current clinical trial will assess the Kaihani Score in 3 groups: Group 1: 10 patients with no personal or…
- Trial name
- NCT04648007
- Testing
- Kaihani Score
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Therapeutic Solutions International